- Guide to PHARMACOLOGY
Compound class: Synthetic organic
Comment: ND-2110 is a potent and selective experimental inhibitor of IRAK4 described in patent WO2013106535  and in a poster presented at the American College of Rheumatology meeting in 2012 (Abstract #1062 in Supplement: Abstracts of the American College of Rheumatology & Association of Rheumatology Health Professionals, Annual Scientific Meeting, November 9-4, 2012 Washington DC, Volume 64, Issue S10, Page S1-S1216).
PubChem CID 68115559 represents this molecule with specified stereochemisrty at only one of the chiral centers.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Compound class||Synthetic organic|
|GtoPdb PubChem SID||249565762|
|RCSB PDB Ligand||CJQ|
|Search Google for chemical match using the InChIKey||VZOLINZYKOLXAC-RBSFLKMASA-N|
|Search Google for chemicals with the same backbone||VZOLINZYKOLXAC|
|UniChem Compound Search for chemical match using the InChIKey||VZOLINZYKOLXAC-RBSFLKMASA-N|
|UniChem Connectivity Search for chemical match using the InChIKey||VZOLINZYKOLXAC-RBSFLKMASA-N|